Penn Capital Management Company, LLC Amarin Corp Plcuk Transaction History

Penn Capital Management Company, LLC

  • $983 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 14, 2020
SELL
$4.78 - $8.26 $1.95 Million - $3.37 Million
-407,532 Closed
0 $0
Q1 2020

May 13, 2020
SELL
$4.0 - $21.53 $65,292 - $351,434
-16,323 Reduced 3.85%
407,532 $1.65 Million
Q4 2019

Feb 12, 2020
SELL
$13.94 - $24.12 $38,279 - $66,233
-2,746 Reduced 0.64%
423,855 $9.09 Million
Q3 2019

Nov 13, 2019
BUY
$13.89 - $23.16 $5.93 Million - $9.88 Million
426,601 New
426,601 $6.47 Million

Others Institutions Holding AMRN

# of Institutions
177
Shares Held
65.1M
Call Options Held
258K
Put Options Held
98K
View Full List

About AMARIN CORP PLCUK

AMRN Quotes by TradingView
  • Ticker AMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 403,206,016
  • Market Cap $194M
  • Description
  • Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...
More about AMRN
Track This Portfolio

Track Penn Capital Management Company, LLC Portfolio

Follow Penn Capital Management Company, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Penn Capital Management Company, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Penn Capital Management Company, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email